Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Organisation Job description In the Engineering and Technology Institute Groningen (ENTEG), we are looking for a talented and motivated PhD candidate on electrochemical ammonia synthesis in Protonic
-
Osbourne. Dr Osbourne’s research explores the link between extractivism, colonialism and outer space. It departs from the observation that mining on earth is essential for devising the technology to go into
-
, Industrial Engineering, Computer Science, or Machine Learning. Solid experience with quantitative optimization methods, including (but not limited to) mathematical programming and stochastic dynamic
-
that values not only economic returns, but also social cohesion, ecological sustainability, and cultural diversity? The circular transition in textiles requires more than technology. It calls for new forms
-
about how artificial intelligence is changing state actor powers? Do you want to conduct critical and in-depth legal research at the intersection of technology, law and power? And would you like
-
: Friday 31 October 2025 About the department You will work in the Integrated Project Delivery (IPD) research group at the faculty of Engineering Technology (ET) of the University of Twente. The Integrated
-
interested in social interaction and language technology? As a PhD candidate, you will investigate a topic at the intersection of human language and interactive interfaces. You will be able to co-design your
-
and networks worldwide to become a truly global centre of knowledge. This 4-year PhD position is embedded in the Artificial Intelligence department at the Faculty of Science and Engineering and in
-
Biomolecular Sciences and Biotechnology Institute (GBB – https://www.rug.nl/gbb ), one of the larger institutes of the Faculty of Science and Engineering (FSE), provides an excellent environment for top-notch
-
deadline: 1 August 2025 Apply now In this PhD position, you will do research within the Biofabrication team with a specific focus on developing an engineered pancreatic endocrine construct to counter Type 1